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Abstract
Little is known about how pro-obesity diets regulate tissue stem and progenitor cell function. Here 
we find that high fat diet (HFD)-induced obesity augments the numbers and function of Lgr5+ 
intestinal stem-cells (ISCs) of the mammalian intestine. Mechanistically, HFD induces a robust 
peroxisome proliferator-activated receptor delta (PPAR-d) signature in intestinal stem and (non-
ISC) progenitor cells, and pharmacologic activation of PPAR-d recapitulates the effects of a HFD 
on these cells. Like a HFD, ex vivo treatment of intestinal organoid cultures with fatty acid 
constituents of the HFD enhances the self-renewal potential of these organoid bodies in a PPAR-d 
dependent manner. Interestingly, HFD- and agonist-activated PPAR-d signaling endow organoid-
initiating capacity to progenitors, and enforced PPAR-d signaling permits these progenitors to 
form in vivo tumors upon loss of the tumor suppressor Apc. These findings highlight how diet-
modulated PPAR-d activation alters not only the function of intestinal stem and progenitor cells, 
but also their capacity to initiate tumors.
The mammalian intestine is known to respond to dietary signals1. Lgr5+ intestinal stem-cells 
(ISCs) remodel intestinal composition in response to diet-induced cues by adjusting their 
production of daughter stem-cells and (non-ISC, transit-amplifying cells) progenitor cells, 
the latter of which differentiate into the diverse cell-types of the intestine1–3. The Lgr5+ 
ISCs reside at the base of intestinal crypts adjacent to Paneth cells, which are a central 
component of the ISC niche and regulate stem cell biology in response to calorie-restricted 
diets1,4.
Although significant epidemiologic and rodent studies link obesity to colon cancer 
incidence3,5–7, little is known about how the adaptation of stem and progenitor cells to pro-
obesity diets alters the potential of these cells to initiate tumors3. In the mouse intestine, 
Lgr5+ ISCs serve as the cell-of-origin for the precancerous adenomatous lesions caused by 
loss of the Apc tumor suppressor gene; yet, it is unclear whether this occurs in the context of 
obesity-linked intestinal tumorigenesis8,9. Here, we interrogate how long-term high fat diet 
(HFD)-induced obesity influences intestinal stem and progenitor cell function and the 
cellular origins of intestinal dysplasia.
HFD boosts ISC counts and crypt function
To assess the effects of obesity on intestinal homeostasis, we maintained mice on a long-
term HFD (60% fat diet; Extended Data 1o) for 9–14 months, which is sufficient to observe 
many of the metabolic phenotypes associated with obesity10,11. Consistent with previous 
reports, HFD-fed mice gained considerably more mass than their standard chow-fed 
counterparts (Extended Data 1a). While the small intestines from HFD-fed mice were 
shorter in length (Extended Data 1c) and weighed less (Extended Data 1b), there was no 
change in the density of crypt-villous units (Extended Data 1d) or in the number of apoptotic 
cells (Extended Data 1n). Morphologically, HFD led to a mild reduction in villi length 
(Extended Data 1g), an associated decrease in villous enterocyte numbers (Extended Data 
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1f), and an increase in crypt depth (Extended Data 1e). A HFD did not change the numbers 
of chromogranin A+ enteroendocrine cells or Alcian blue+ goblet cells per crypt-villus unit 
of the small intestine (Extended Data 2a–d).
To address how HFD affects the frequency of intestinal stem-cells, we performed in situ 
hybridization for olfactomedin 4 (Olfm4), a marker expressed by the Lgr5+ ISCs12. 
Compared to mice fed a regular chow diet, those on a HFD had a 50% increase in the 
number of Olfm4+ ISCs (Fig. 1a, Extended Data 1l). In contrast, a HFD reduced Cryptdin 4+ 
niche Paneth cell numbers by 23% (Fig. 1a, Extended Data 1m). These observations lead to 
two conclusions: first, HFD enhances ISCs numbers and self-renewal (e.g. deeper crypts 
with more Olfm4+ ISCs) at the expense of differentiation (e.g. shorter and less cellular villi); 
and, second, the increase in ISCs occurs despite a reduction in Paneth cell numbers, raising 
the possibility that under a HFD ISCs adjust to fewer interactions from their Paneth cell 
niche.
Given that ISC numbers and proliferation (Fig. 1b, Extended Data 1h–k, 3f, See 
Supplementary Information) increase in a HFD, we asked whether a HFD also boosts 
intestinal regeneration. Using an in vitro approach, we assessed the ability of isolated 
intestinal crypts to form organoid bodies in 3-D culture. These organoids recapitulate the 
epithelial architecture and cellular diversity of the mammalian intestine and are a proxy for 
ISC activity, as only stem-cells can initiate and maintain these structures long-term1,13. 
HFD-derived crypts from the small intestine and colon were more likely to initiate mini-
intestines in culture than those from controls (Fig. 1c, e, Extended Data 3j). Furthermore, 
these organoids were more cystic (i.e. less differentiated14) in structure and contained fewer 
crypt domains (Fig. 1d). When sub-cloned, HFD-derived primary organoids generated more 
secondary organoids (Fig. 1f, Extended Data 3k). Consistent with these findings, HFD crypt-
derived organoids had higher frequencies of Lgr5+ ISCs compared to controls (Extended 
Data 4a, d, e) and possessed diverse intestinal cell types, such as Paneth cells, ISCs, 
enteroendocrine cells and goblet cells (Extended Data 4b–f).
To determine whether HFD also augments crypt regeneration in vivo, we performed a 
clonogenic microcolony assay to test for ISC activity1,15. After administration of a lethal 
dose of irradiation, HFD-fed mice manifested increased numbers of surviving, proliferating 
crypts (Ki67+ cells/crypt) that possessed more Olfm4+ ISCs per unit length of intestine 
relative to controls (Extended Data 2e–g). These data support the notion that a HFD boosts 
the numbers and regenerative capacity of ISCs in vitro and in vivo.
HFD reduces the niche dependence of ISCs
To assess the effects of a HFD on ISCs and progenitors, we utilized Lgr5-EGFP-IRES-
CreERT2 knock-in mice for the quantification and isolation of Lgr5-GFPhi stem and Lgr5-
GFPlow progenitor cells2. Compared to controls, mice on a HFD had an increased frequency 
of Lgr5-GFPhi ISCs in the small intestine (Fig. 1g) and colon (Fig. 1h, Extended Data 3g).
The opposing effects of HFD on ISC and Paneth cell numbers led us to ask whether HFD 
alters ISC function and niche dependence. We assayed the clonogenic potential of ISCs from 
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control and HFD-fed mice either alone or in combination with the niche Paneth cells1. 
Consistent with earlier studies1,4,13, control ISCs by themselves inefficiently formed 
organoids, but robustly formed organoids when co-cultured with Paneth cells (Fig. 1i). 
Surprisingly, HFD-derived ISCs by themselves (i.e. without Paneth cells) had an increased 
capacity to initiate organoids with multilineage differentiation and more secondary 
organoids compared to control ISCs. (Fig. 1i–k, Extended Data 4h, i, l, m). Co-culture with 
Paneth cells further increased the organoid-initiating activity of HFD ISCs (Fig. 1i). 
Organoids derived from control and HFD ISCs alone effectively produced Paneth cells 
within 24 hours of culture (Extended Data 4j, k). Also, crypts and ISCs isolated from mice 
that had been on a HFD, but were returned to a standard chow diet, retained an enhanced 
capacity to initiate organoids for more than 7 days but less than 4 weeks, indicating that the 
effects of a HFD are reversible (Fig. 1l, m). These data, together with the observation that 
HFD uncouples the in vivo expansion of ISCs from their Paneth cell niche, suggest ISCs 
undergo autonomous changes in response to a HFD that poises them for niche-independent 
growth in the organoid assay.
Fatty acids drive organoid self-renewal
To address whether dietary constituents of the HFD can recapitulate aspects of the HFD-
evoked stem-cell phenotype, we expanded control organoids in crypt media supplemented 
with palmitic acid (PA), a main component of the HFD16. Treatment with PA did not alter 
the clonogenic potential of control crypts in primary culture (Fig. 2a). However, as observed 
with organoids from HFD mice, primary organoids exposed ex vivo to PA gave rise to more 
secondary organoids compared to controls (Fig. 2b, c, Extended Data 5a). Consistent with 
these findings, organoids treated with PA possessed nearly 2-fold more Lgr5+ ISCs (Fig. 2d, 
Extended Data 5b) and manifested reduced niche dependence in the organoid assay (Fig. 
2e). Similar results were obtained with other fatty acids such as oleic acid and a lipid 
mixture in mouse and human intestinal organoids (Fig 3h–k, Extended Data 5c–f). These 
findings indicate that key dietary constituents of HFD are sufficient to recapitulate aspects of 
the in vivo HFD stem-cell phenotype.
HFD acts through PPAR-d in ISCs
To gain mechanistic insight into how HFD mediates these effects, we performed mRNA-
sequencing on isolated Lgr5-GFPhi ISCs and Lgr5-GFPlow progenitor cells from control and 
HFD-fed mice, respectively (Extended Data 6p). GSEA pathway and transcription factor 
binding motif analyses revealed enrichment for transcriptional targets and binding motifs of 
the nuclear receptor PPAR (peroxisome proliferator-activated receptor) family and PPAR 
heterodimeric binding partners liver/retinoid X receptor (LXR/RXR; Extended Data 6c, 
d)17–19. Three members (alpha, delta, and gamma) comprise the PPAR family17; amongst 
these PPAR-delta (PPAR-d) is the predominant one expressed in intestinal stem and 
progenitor cells at the mRNA level in control and HFD mice (Extended Data 6a, b). 
Therefore, we focused our attention on PPAR-d and its potential role in coupling a HFD to 
ISC function.
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Although PPAR-d expression itself did not substantially increase (Extended Data 6a, b), the 
HFD robustly induced expression of many of its target genes at the mRNA levels in both 
small intestine (Extended Data 6e) and colon (Extended Data 3h). The induction of the 
PPAR-d program was verified at the protein level in ISCs and progenitors (Fig. 3a). To 
address functionally whether engagement of a PPAR-d program mimics the HFD, we 
administered the PPAR-d agonist GW501516 (GW) for 4 weeks to Lgr5-EGFP-IRES-
CreERT2 mice20,21. Treatment led to strong induction of PPAR-d target proteins in ISCs and 
progenitors (Fig. 3a). Furthermore, agonist-activated PPAR-d signaling augmented the in 
vivo frequencies of Olfm4+ and Lgr5+ ISCs (Fig. 3b, e, Extended Data 6f) and proliferation 
of stem and progenitors cells (Fig. 3c) but had no impact on Paneth cell numbers (Fig. 3b, 
Extended Data 6g). Notably, small intestinal (Fig. 3d) and colonic (Extended Data 3l, m) 
crypts from agonist-treated mice initiated more organoids than those from vehicle-treated 
mice. Similar to ISCs from HFD mice, ISCs derived from agonist-treated mice were more 
effective at Paneth cell-independent organoid-initiation than their control counterparts (Fig. 
3f). In addition, organoids exposed to the PPAR-d agonist had more Lgr5+ ISCs (Fig. 3g) 
and more self-renewing capacity in secondary assays (Fig. 3i). These data indicate that 
sustained PPAR-d signaling largely recapitulates the effects of a HFD on ISC function.
Because ex vivo fatty acids mimic aspects of a HFD, we asked whether this phenomenon 
occurs through PPAR-d signaling. Like HFD, we observed that ex vivo exposure of mouse 
and human organoids to fatty acids evokes a robust PPAR-d program (Extended Data 5g–j, 
6h). To assess the necessity of PPAR-d in this response to fatty acids, we generated 
tamoxifen-inducible, intestine-specific Ppard conditional mice (Ppard IKO, Extended Data 
6i, j). Acute ablation of Ppard in the intestine had no noticeable effects on the numbers, 
proliferation, or function of ISCs and progenitor cells (Fig. 3h, Extended Data 6i–n). 
However, loss of Ppard blocked the self-renewal enhancing effects of fatty acids and PPAR-
d agonist in secondary assays (Fig. 3i, j) as well as the induction of PPAR-d target gene 
expression in secondary organoid assays (Extended Data 6o). These findings demonstrate 
that PPAR-d mediates fatty acid-driven organoid self-renewal.
HFD and PPAR-d raise β-catenin activity
Because HFD and PPAR-d activation confer increased stem cell function, we asked whether 
these interventions regulate the Wnt/β-catenin pathway, which is required for ISC 
maintenance2,22. First, we observed more nuclear β-catenin, a proxy for its activity, in sorted 
ISCs and progenitors and on intestinal sections from HFD and PPAR-d agonist-treated mice 
compared to controls (Extended Data 7c–i). Second, crypts from HFD and PPAR-d agonist-
treated mice required less exogenous Wnt for organoid maintenance than controls (Fig. 4a, 
b). Lastly, we found that increased levels of nuclear β-catenin associate with PPAR-d in 
HFD crypts (Extended Data 7j–l).
To address how a HFD and agonist-activated PPAR-d influence β-catenin transcriptional 
activity, we performed microfluidic-based multiplexed single cell qRT-PCR using primers 
for a curated list of known β-catenin target genes that includes intestinal stem-cell markers 
(Supplementary Table 2, Extended Data 8a, d, See Supplementary Information). While a 
HFD did not alter expression of stem-cell signature genes (i.e. Lgr5) that differ between 
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stem and progenitor cells (Extended Data 8b, e, g, h)23,24, it evoked expression of a subset of 
β-catenin target genes such as Bmp4, Jag1, Jag2 and Edn3 in ISCs and progenitors (Fig. 4c, 
e, Extended Data 3i, 8c, i, j). Single cell qRT-PCR analysis confirmed that agonist-activated 
PPAR-d also induced transcription of Bmp4, Jag1, Jag2 and Edn3 in ISCs and progenitors 
(Fig. 4d, f). We further validated Jag-1 expression by single molecule in situ hybridization 
and found that it was broadly expressed within HFD (Extended Data 8k) and PPAR-d 
agonist-treated crypts (Extended Data 8l). Moreover, in response to in vitro fatty acids, 
PPAR-d was required for the induction of Jag1 and Jag2 in secondary organoids (Extended 
Data 6o). Collectively, these results support a model in which HFD activates a PPAR-d 
mediated subset of β-catenin target genes in ISCs and progenitor cells.
To interrogate whether a similar program exists in an alternate model of obesity, we assessed 
how the intestine adapts to obesity in leptin receptor deficient (db/db) mice—an obesity 
model that develops on a standard diet. Overall, we found that intestinal adaptation in the 
db/db obesity model was mostly opposite to what we observed in HFD-fed mice (Extended 
Data 9 and See Supplementary Information). Such differences highlight that, even in obesity, 
diet impacts intestinal stem and progenitor biology.
PPAR-d permits non-ISCs to beget tumors
It is understood that somatic stem-cells often accumulate the initial mutations that lead to 
oncogenic transformation3,8,25–27. We found that in a HFD there is a greater incidence of 
spontaneous intestinal low-grade dysplastic lesions (adenomas), carcinomas, or both than in 
controls (Fig. 5a–c), which may reflect the fact that there are more ISCs in mice on a HFD 
that can acquire oncogenic mutations. Because HFD-induced PPAR-d also activates a β-
catenin signature in progenitor cells, we hypothesized that non-ISC progenitor populations 
can acquire stem-cell features and contribute to tumor initiation in diet-induced obesity3,27. 
To explore this possibility, we asked whether HFD or agonist-activated PPAR-d influenced 
the organoid-initiating capacity of progenitors (non-ISCs). Interestingly, Lgr5-GFPlow 
progenitors, but not terminally differentiated villous enterocytes, from HFD and PPAR-d 
agonist treated mice formed organoids (Fig. 5d, e, Extended Data 4g, 7a, b), raising the 
possibility that enforced PPAR-d signaling in intestinal progenitors not only bestows 
organoid-initiating capacity but also tumor-initiating potential.
To test this possibility, we generated ApcL/L; Lgr5-EGFP-IRES-CreERT2 mice to assess 
whether pharmacological PPAR-d activation modifies the tumorigenic capacity of the Lgr5-
GFPlow progenitors. Injection with tamoxifen leads to Apc loss in the Lgr5-GFPhi ISCs, 
which in turn generate Apc-null Lgr5-GFPlow progenitors (Extended Data 10c). Four days 
after tamoxifen administration, we isolated Apc-null Lgr5-GFPhi ISCs and Lgr5-GFPlow 
progenitors from vehicle and PPAR-d agonist treated mice to assess the tumor-forming 
potential of these populations using separate assays (Fig. 5f schematic): first, we examined 
their capacity to give rise to adenomatous organoids in culture; and second, we interrogated 
the ability of 10,000 sorted stem and progenitor cells to initiate adenomas in syngeneic 
recipient colons.
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We found that Apc-null ISCs from PPAR-d agonist-treated mice were as clonogenic as those 
from vehicle controls; however, enforced PPAR-d signaling in Apc-null progenitors 
dramatically boosted their ability to form adenomatous organoids (Fig. 5g). Next, we 
assessed the potential of freshly isolated intestinal stem and progenitor cells to form in vivo 
intestinal adenomas (Fig. 5f schematic). As in the organoid assay, the PPAR-d agonist had 
no additive effect on the ability of Apc-null stem-cells to form β-catenin+ (Apc-null) 
adenomas (Fig. 5h, Extended Data 10a, d) compared to the vehicle controls. However, 
enforced PPAR-d signaling permitted Apc-null progenitors, but not their vehicle-treated 
counterparts, to robustly initiate β-catenin+ (Apc-null) adenomas upon transplantation into 
recipient colons (Fig. 5h, Extended Data 10b, d). These data indicate that PPAR-d activation 
enables a subset of non-ISC progenitors to initiate adenomatous growth in vitro and in vivo 
(See Supplementary Information).
Discussion
Our data favor a model in which a HFD augments ISC self-renewal and bestows features of 
stemness (i.e. organoid-initiating capacity) on non-stem cell progenitors by activating PPAR-
d signaling (Fig. 5i). A previous study shows that a different dietary regimen, calorie 
restriction, increases both stem and Paneth cell numbers and regulates ISC function non-cell 
autonomously through the Paneth cell niche with no significant effect on progenitor cell 
function1. In contrast, here we find that a long-term HFD has opposing effects on stem and 
Paneth cell numbers and that these stem cells are less dependent on Paneth cells in 
functional assays. The fact that we find induction of β-catenin targets Jag1 and Jag2 (Notch 
ligands typically elaborated by Paneth cells) in HFD stem and progenitor cells suggests a 
possible role for Notch signaling. In a HFD, proximate ISCs or progenitor cells may serve as 
a surrogate source of Notch ligands for Lgr5+ ISCs not in direct contact with Paneth cells, 
enabling them to persist in vivo and in the organoid assay. A recent report28 that PPAR-d 
activation in the bone amplifies β-catenin signaling is consistent with our finding that diet-
activated PPAR-d engages a restricted β-catenin program. Notably, genes within the PPAR-
d-activated β-catenin program include Jag1, Jag2, and Bmp4, which are often deregulated in 
early intestinal tumorigenesis (Fig. 4c–f)29–31.
Recent studies propose that intrinsic and extrinsic factors contribute to cancer risk through 
the control of stem-cell divisions 25,32. These models predict that extrinsic factors such as a 
HFD may elevate cancer risk by increasing stem-cell divisions, which are the implicated 
cell-of-origin for many cancers. Our data (Figure 5i) and a previous study33 demonstrate that 
a HFD augments the numbers and proliferation of ISCs, which may partially account for the 
increase of intestinal tumors in this model of obesity. Another possibility raised by our 
results is that a HFD-driven PPAR-d program also enhances the susceptibility of non-ISCs to 
undergo oncogenic transformation, thus establishing a larger and more diverse pool of cells 
capable of initiating tumors. Consistent with this notion, it has been proposed that 
differentiated cells (i.e. non-ISCs) in the background of Apc-deficiency with concurrent 
activation of oncogenic KRAS and pro-inflammatory NF-kB signaling have the capacity to 
initiate tumors9. Whether and how obesity-related inflammation in a HFD contributes to 
PPAR-d signaling and intestinal tumorigenesis is unknown. In our models, we find no 
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evidence that a HFD or its predominant fatty acid constituents activate inflammatory 
pathways in intestinal crypts34 or organoids, respectively (Extended Data 3a–e).
While some previous work indicates that PPAR-d inhibition may have modest anti-cancer 
effects19, sustained PPAR-d activation and a HFD have been linked to colorectal cancer 
initiation and progression7,35–40. Future studies will need to address whether PPAR-d 
inhibition in the setting of a HFD impacts tumor initiation and progression. Lastly, it will be 
important to explore if lean ketogenic diets, which like a HFD are composed largely of fatty 
acids but with fewer carbohydrates, mimic the pro-regenerative effects of a HFD while 
minimizing the untoward sequelae of obesity.
Materials and Methods
Mice, High Fat Diet, and drug treatment
Mice were housed in the Unit for Laboratory Animal Medicine at the Whitehead Institute 
for Biomedical Research and Koch Institute for Integrative Cancer Research. The following 
strains were obtained from the Jackson Laboratory: Lgr5-EGFP-IRES-CreERT2 (strain 
name: B6.129P2-Lgr5tm1(cre/ERT2)Cle/J, stock number 008875), Rosa26-lacZ (strain name: 
B6.129S4-Gt(ROSA)26Sortm1Sor/J, stock number 003474), db/db (strain name: B6.BKS(D)-
Leprjb/J, stock number 000697), PpardL/L (strain name: B6.129S4-Ppardtm1Rev/J, stock 
number 005897). Apcloxp exon 14 (ApcL/L) has been previously described41. Villin-CreERT2 
was a gift from Sylvie Robine. Long-term high fat diet was achieved by feeding male and 
female mice a dietary chow consisting of 60 kcal% fat (Research Diets D12492) beginning 
at the age of 8–12 weeks and extending for a period of 9 to 14 months. Control mice were 
sex and age-matched and fed standard chow ad libitum. GW501516 (Enzo) was 
reconstituted in DMSO at 4.5 mg ml−1 and diluted 1:10 in a solution of 5% PEG400 
(Hampton Research), 5% Tween80 (Sigma), 90% H2O for a daily intraperitoneal injection 
of 4 mg kg−1. Apc exon 14 was excised by tamoxifen suspended in sunflower seed oil 
(Spectrum S1929) at a concentration of 10 mg ml−1 and 250 μl per 25g of body weight, and 
administered by intraperitoneal injection twice over 4 days before harvesting tissue. 
PpardL/L mice were administered four to five I.P. injections of tamoxifen on alternate days. 
Mice were analyzed within two weeks of the last tamoxifen injection. BrdU was prepared at 
10 mg ml−1 in PBS, passed through 0.22 μm filter and injected at 100 mg kg−1.
Immunohistochemistry (IHC) and immunofluorescence (IF)
As previously described1, tissues were fixed in 10% formalin, paraffin embedded and 
sectioned. Antigen retrieval was performed with Borg Decloaker RTU solution (Biocare 
Medical) in a pressurized Decloaking Chamber (Biocare Medical) for 3 minutes. Antibodies 
used: rat anti-BrdU (1:2000 (IHC), 1:1000 (IF) Abcam 6326), rabbit chromogranin A 
(1:4000 (IHC), 1:250 (IF), Abcam 15160), rabbit monoclonal non-phospho β-catenin 
(1:800(IHC), 1:400(IF), CST 8814S), mouse monoclonal β-catenin (1:200, BD Biosciences 
610154), rabbit polyclonal lysozyme (1:250, Thermo RB-372-A1), rabbit polyclonal MUC2 
(1:100, Santa Cruz Biotechnology 15334), rabbit monoclonal OLFM4 (1:10,000, gift from 
CST, clone PP7), Biotin-conjugated secondary donkey anti-rabbit or anti-rat antibodies were 
used from Jackson ImmunoResearch. The Vectastain Elite ABC immunoperoxidase 
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detection kit (Vector Labs PK-6101) followed by Dako Liquid DAB+ Substrate (Dako) was 
used for visualization. For immunofluorescence, Alexa Fluor 568 secondary antibody 
(Invitrogen) was used with Prolong Gold (Life Technologies) mounting media. All antibody 
incubations involving tissue or sorted cells were performed with Common Antibody Diluent 
(Biogenex). Organoids were fixed with 4%PFA, permabilized with 0.5%TritonX-100/PBS, 
rinsed with 100mM glycine/PBS, blocked with 10% Donkey serum/PBS, incubated 
overnight with primary antibody at 4°C, rinsed and incubated with Alexa Fluor 568 
secondary antibody (Invitrogen), and mounted with Prolong Gold (Life Technologies) 
mounting media.
In situ hybridization
The in situ hybridization probes used in this study correspond to expressed sequence tags or 
fully sequenced cDNAs obtained from Open Biosystems. The accession numbers (IMAGE 
mouse cDNA clone in parenthesis) for these probes are as follows: mouse Olfm4 BC141127 
(9055739), mouse Cryptdin4 BC134360 (40134597). Both sense and antisense probes were 
generated to ensure specificity by in vitro transcription using DIG RNA labeling mix 
(Roche) according to the manufacturer’s instructions and to previously published detailed 
methods23,42. Single-molecule in situ hybridization was performed using Advanced Cell 
Diagnostics RNAscope 2.0 HD Detection Kit.
Radiation and clonogenic microcolony assay
Adult mice were exposed to 15 Gy of ionizing irradiation from a 137-cesium source 
(GammaCell) and sacrificed after 72 hours. The number of surviving crypts per length of the 
intestine was enumerated from haematoxylin and eosin stained sections15.
Immunopreciptation and Immunoblotting
Antibodies: rabbit polyclonal anti-PPAR-d (1:100, Thermo PA1-823A), rabbit polyclonal 
anti-CPT1a (1:250, ProteinTech 15184-1-AP), rabbit polyclonal anti-HMGCS2 (1:500, 
Sigma AV41562), rabbit monoclonal anti-FABP1 (1:1000, Abcam ab129203), NF-kappaB 
Sampler Pathway Kit (CST, 9936S), mouse monoclonal anti-STAT-3 (CST, 9139P), rabbit 
monoclonal anti-P-STAT3 (Y705) XP (CST, 9145P), mouse monoclonal anti-CREB (CST, 
86B10), mouse monoclonal anti-β-catenin (1:200, BD Biosciences 610154), rabbit 
polyclonal anti-γ-tubulin (1:1000, Sigma T5192). For immunoprecipitation (IP) assays, 
crypts were harvested and nuclear extraction was carried out using Abcam nuclear extraction 
kit (ab113474) following manufacturer’s instructions. Nuclear extracts were incubated with 
5μg anti-PPAR-d antibody (Thermo), or anti-rabbit IgG control antibody (Santa Cruz) 
overnight at 4°C followed by 2 hours of incubation with Dynabeads Protein G for 
immunoprecipitation. Protein complexes bound to antibody and beads were washed 5 times 
and eluted with Laemmli sample buffer. Samples were resolved by SDS-PAGE. Protein 
interaction was analyzed by immunoblotting.
Lgr5-GFPhi ISCs or Lgr5-GFPlow progenitors were sorted directly into Laemmli sample 
buffer and boiled for five minutes. Samples were resolved by SDS-PAGE and analyzed by 
immunoblotting with IgG-HRP secondary antibodies (1:10,000, Santa Cruz Biotechnology 
sc-2054) and Western Lightning Plus-ECL detection kit (Perkin Elmer, NEL104001EA).
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Flow cytometry and isolation of ISCs, colonic stem-cells, and Paneth cells
As previously reported and briefly summarized here, small intestines and colons were 
removed, washed with cold PBS−/−, opened longitudinally, and then cut into 3–5mm 
fragments. Pieces were washed multiple times with cold PBS−/− until clean, washed 2–3 
with PBS−/−/EDTA (10mM), incubated on ice for 90–120 minutes, and gently shook at 30-
minute intervals. Crypts were then mechanically separated from the connective tissue by 
more rigorous shaking, and then filtered through a 70-μm mesh into a 50-ml conical tube to 
remove villus material (for small intestine) and tissue fragments. Crypts were removed from 
this step for crypt culture experiments and embedded in Matrigel™ with crypt culture media. 
For ISC isolation, the crypt suspensions were dissociated to individual cells with TrypLE 
Express (Invitrogen). Cell labeling consisted of an antibody cocktail comprising CD45-PE 
(eBioscience, 30-F11), CD31-PE (Biolegend, Mec13.3), Ter119-PE (Biolegend, Ter119), 
CD24-Pacific Blue (Biolegend, M1/69), CD117-APC/Cy7 (Biolegend, 2BS), and EPCAM-
APC (eBioscience, G8.8). ISCs were isolated as Lgr5-
EGFPhiEpcam+CD24low/−CD31−Ter119−CD45−7-AAD−. EGFPlow progenitors were 
isolated as EGFPlowEpcam+CD24low/−CD31−Ter119−CD45−7-AAD−, and Paneth cells from 
small intestine were isolated as CD24hiSidescatterhiLgr5-
EGFP−Epcam+CD31−Ter119−CD45−7-AAD− with a BD FACS Aria II SORP cell sorter 
into supplemented crypt culture medium for culture. Dead cells were excluded from the 
analysis with the viability dye 7-AAD (Life Technologies). When indicated, populations 
were cytospun (Thermo Cytospin 4) at 800 r.p.m. for 2 minutes, or allowed to settle at 37°C 
in fully humidified chambers containing 5% CO2 onto poly-L-lysine-coated slides 
(Polysciences). The cells were subsequently fixed in 4% paraformaldehyde (pH 7.4, 
Electron Microscopy Sciences) before staining.
Culture media for crypts and isolated cells
Isolated crypts were counted and embedded in Matrigel™ (Corning 356231 growth factor 
reduced) at 5–10 crypts per μl and cultured in a modified form of medium as described 
previously13. Unless otherwise noted, Advanced DMEM (Gibco) was supplemented by EGF 
40 ng ml−1 (R&D), Noggin 200 ng ml−1 (Peprotech), R-spondin 500 ng ml−1 (R&D or Sino 
Biological), N-acetyl-L-cysteine 1 μM (Sigma-Aldrich), N2 1X (Life Technologies), B27 
1X (Life Technologies), Chiron 10 μM (Stemgent), Y-27632 dihydrochloride monohydrate 
20 ng ml−1 (Sigma-Aldrich). Colonic crypts were cultured in 50% conditioned medium 
derived from L-WRN cells supplemented with Y-27632 dihydrochloride monohydrate 20 ng 
ml−1, as described43. 25–30μL droplets of Matrigel™ with crypts were plated onto a flat 
bottom 48-well plate (Corning 3548) and allowed to solidify for 20–30 minutes in a 37°C 
incubator. Three hundred microliters of crypt culture medium was then overlaid onto the 
Matrigel™, changed every three days, and maintained at 37°C in fully humidified chambers 
containing 5% CO2. Clonogenicity (colony-forming efficiency) was calculated by plating 
50–300 crypts and assessing organoid formation 3–7 days or as specified after initiation of 
cultures. Palmitic acid (Cayman Chemical Company 10006627 conjugated to BSA), oleic 
acid (Sigma O1008), lipid mixture (Sigma L0288), or GW501516 (Enzo) were added 
immediately to cultures at 30 μM (PA, OA), 2% (lipid mixture), and 1μM (GW501516). 4-
OH tamoxifen (Calbiochem, 579002, 10nM) was added to organoid cultures derived from 
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PpardL/L; Villin-CreERT2 (PPARdIKO) crypts to ensure Ppard excision in the ex vivo fatty 
acid or GW501516 experiments.
Isolated ISCs or progenitor cells were centrifuged for 5 minutes at 250g, re-suspended in the 
appropriate volume of crypt culture medium (500–1,000 cells μl−1), then seeded onto 25–
30μl Matrigel™ (Corning 356231 growth factor reduced) containing 1μM Jagged (Ana-
Spec) in a flat bottom 48-well plate (Corning 3548). Alternatively, ISCs and Paneth cells 
were mixed after sorting in a 1:1 ratio, centrifuged, and then seeded onto Matrigel™. The 
Matrigel™ and cells were allowed to solidify before adding 300 μl of crypt culture medium. 
The crypt media was changed every second or third day. Organoids were quantified on days 
3, 7 and 10 of culture, unless otherwise specified.
Secondary murine organoid assays
For secondary organoid assays, either individual primary organoids or many primary 
organoids were either mechanically dissociated and then replated or organoids were 
dissociated for 10 minutes in TrypLE Express at 32°C, resuspended with SMEM (Life 
Technologies), centrifuged (5 minutes at 250g) and then resuspended in cold SMEM with 
the viability dye 7-AAD. Live cells were sorted and seeded onto Matrigel™ as previously 
described in standard crypt media (not supplemented with lipids or GW501516). Secondary 
organoids were enumerated on day 4, unless otherwise specified.
Human crypt cultures
Human biopsies were obtained from patients with informed consent undergoing intestinal 
resection at the Massachusetts General Hospital (MGH). The MGH Institutional Review 
Board committee and Massachusetts Institute of Technology Committee on the Use of 
Humans as Experimental Subjects approved the study protocols. Crypts were isolated43, 
embedded in Matrigel™ and subsequently exposed to lipid mixture, palmitic acid, or 
GW501516 (as described in the previous section, entitled “Culture media for crypts and 
isolated cells”). Cultures were passaged weekly and maintained for 3–4 weeks. To passage, 
equal numbers of organoids from each condition were disrupted with trypsin/EDTA. 
Numbers of organoids were counted 4–7 days after passaging into control media. Counts 
were normalized to numbers of organoids present in control wells and plotted. Statistical 
significance was calculated by performing ANOVA multiple comparisons of the means for 
each group. For quantitative RNA expression analysis, organoids were dissociated, cells 
were selected as a live population by flow cytometry (7-AAD, Life Technologies), and 
sorted into Tri Reagent (Life Technologies) for RNA isolation.
Electron microscopy
After 5 days of culturing, intestinal organoids were placed into Karnovsky’s KII solution 
(2.5% glutaraldehyde, 2.0% paraformaldehyde, 0.025% calcium chloride, in a 0.1 M sodium 
cacodylate buffer, pH 7.4) and fixed overnight. Subsequently, they were postfixed in 2.0% 
osmium tetroxide, stained en bloc with uranyl acetate, dehydrated in graded ethanol 
solutions, infiltrated with propylene oxide/Epon mixtures, flat embedded in pure Epon, and 
polymerized over night at 60°C. One-micrometer sections were cut, stained with toluidine 
blue, and examined by light microscopy. Representative areas were chosen for electron 
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microscopic study and the Epon blocks were trimmed accordingly. Thin sections were cut 
with an LKB 8801 ultramicrotome and diamond knife, stained with Sato’s lead, and 
examined in a FEI Morgagni transmission electron microscope. Images were captured with 
an AMT (Advanced Microscopy Techiques) 2K digital CCD camera.
mRNA-Sequencing
RNA Isolation—For RNA-seq, total RNA was extracted from 200K sorted Lgr5-GFPhi 
ISCs and Lgr5-GFPlow progenitors by pooling two to five 71-week old HFD male or control 
mice using Tri Reagent (Life Technologies) according to the manufacturer’s instructions, 
except for a overnight isopropanol precipitation at −20°C. From the total RNA, poly(A)+ 
RNA was selected using Oligo(dT)25-Dynabeads (Life technologies) according to the 
manufacturer’s protocol.
RNA-Seq Library Preparation—Strand-specific RNA-seq libraries were prepared using 
the dUTP-based, Illumina-compatible NEXTflex Directional RNA-Seq Kit (Bioo Scientific) 
according to the manufacturer’s directions. All libraries were sequenced with an Illumina 
HiSeq 2000 sequencing machine.
Processing of RNA-seq reads and measuring expression level—For RNA-seq 
data analysis, raw stranded reads (40 nt) were trimmed to remove adapter and bases with 
quality scores below 20, and reads shorter than 35 nt were excluded. High-quality reads 
were mapped to the mouse genome (mm10) with TopHat version 1.4.144, using known 
splice junctions from Ensembl Release 70 and allowing at most 2 mismatches. Genes were 
quantified with htseq-count (with the “intersect strict” mode) using Ensembl Release 70 
gene models. Gene counts were normalized across all samples using estimateSizeFactors() 
from the DESeq R/Bioconductor package45. Differential expression analysis was also 
performed between two samples of interest with DESeq. Gene Set Enrichment analysis 
(www.broadinsitute.org/gsea) was performed by using the pre-ranked (according to their 
ratios) 8,240 differentially expressed genes as the expression data set. Motif Analysis was 
performed using Haystack motif enrichment tool: http://github.com/lucapinello/Haystack46.
Single-Cell Gene Expression Analysis
24 single Lgr5-GFPhi ISCs and 72 single Lgr5-GFPlow progenitor cells were sorted from 
control or HFD mice (n=2 mice per group) for single-cell gene expression analysis. For one-
tube single-cell sequence-specific preamplification, individual primer sets of β-catenin target 
genes (total of 96, Supplementary Table 2) were pooled to 0.1 mM final concentration for 
each primer. Single cells were directly sorted into 96-well plates containing 5ul RT-PCR 
master mix (2.5ul CellsDirect reaction mix, Invitrogen; 0.5ul primer pool; 0.1ul RT/Taq 
enzyme, Invitrogen; 1.9ul nuclease free water) in each well. Immediately after, plates were 
placed on PCR machine for preamplification. Sequence specific preamplification PCR 
protocol was as following: 1) 60 minutes at 50°C for cell lysis and sequence specific reverse 
transcription. 2) 3 minutes at 95°C for reverse transcriptase inactivation and Taq polymerase 
activation. Then, cDNA was amplified by 20 cycles of 15 seconds at 95°C for initial 
denaturation, 15 minutes at 60°C for annealing and elongation. After preamplificiation, 
samples were diluted 1:5 prior to high throughput microfluidic real time PCR analysis using 
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Fluidigm platform. Amplified single cell cDNA samples were assayed for gene expression 
using individual qRT-PCR primers and 96.96 dynamic arrays on a BioMark System by 
following manufacturers protocol (Fluidigm). To confirm PPAR-d mediated induction of the 
most upregulated genes (n=3 mice, 24 ISCs and 72 progenitors per group), or for single cell 
analysis of organoid composition (n=3 mice, 48 cells per group) and db/db mice (n=3, 48 
cells per group) standard single-cell qRT-PCR was performed using preamplified cDNA 
with corresponding primers. For Fluidigm analysis, threshold cycle (Ct) values were 
calculated using the BioMark Real-Time PCR Analysis software (Fluidigm). (See 
Supplementary Information for raw gene expression data). Gene expression levels were 
estimated by subtracting the Ct values from the background level of 35, which 
approximately represent the log2 gene expression levels. The t-Distributed stochastic 
neighbor embedding (t-SNE) analysis47 was performed using the MATLAB toolbox for 
dimensionality reduction. Differential expression analysis was conducted using the two-
sided Wilcoxon- Mann-Whitney rank sum test implemented in the R coin package (www.r-
project.org). P-values were adjusted for multiple testing48 using the p.adjust function in R 
with method=“fdr” option. Fold-changes were calculated as the difference of median of log2 
expression levels for the two cell populations. Split violin plots were generated using the 
vioplot package and the vioplot2 function in R (https://gist.github.com/mbjoseph/5852613). 
The heatmap for β-catenin target genes was generated with the MultiExperiment Viewer 
(MeV) program (http://www.tm4.org/mev.html) using the correlation-based distance and 
average linkage method as parameters of the unsupervised hierarchical clustering of genes. 
The heatmap for organoid composition was generated using MATLAB. The percentages of 
Jag1/Jag2 upregulated cells were calculated based on the number of single cells whose log2 
expression was above 15.
qRT-PCR
25.000 cells were sorted into Tri Reagent (Life Technologies) and total RNA was isolated 
according to the manufacturer’s instructions with following modification: the aqueous phase 
containing total RNA was purified using RNeasy plus kit (Qiagen). RNA was converted to 
cDNA with cDNA synthesis kit (Bio-Rad). qRT-PCR was performed with diluted cDNA 
(1:5) in 3 wells for each primer and SYBR green master mix (Bio-Rad) on Bio-Rad iCycler 
RT-PCR detection system. For organoid experiments, 1000 live cells were sorted and qRT-
PCR optimized for low cell numbers (<1000) was performed after sequence specific pre-
amplification (cDNA diluted 1:200 in 3 wells for each primer) as described in single-cell 
gene expression analysis. All qRT PCR experiments were repeated at least 3 independent 
times. Primers used are listed on Supplementary Table 1.
Orthotopic transplantation
ApcL/L; Lgr5-EGFP-IRES-CreERT2 mice were treated with vehicle or GW501516 for one 
month, and then injected with two doses of tamoxifen I.P. Four days later, Apc-null Lgr5-
GFPhi ISCs and Lgr5-GFPlow progenitors were sorted by flow cytometry, as described 
above. For primary cell transplantations, 10,000 Apc-null Lgr5-GFPhi ISCs and Lgr5-
GFPlow progenitors were resuspended into 90% crypt culture media (as described) and 10% 
Matrigel™, then transplanted into the colonic lamina propria of C57BL/6 recipient mice by 
optical colonoscopy using a custom injection needle (Hamilton Inc., 33 gauge, small Hub 
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RN NDL, 16 inches long, point 4, 45 degree bevel, like part number 7803-05), syringe 
(Hamilton Inc., part number 7656-01), and transfer needle (Hamilton Inc., part number 
7770-02). Optical colonoscopy was performed using a Karl Storz Image 1 HD Camera 
System, Image 1 HUB CCU, 175 Watt Xenon Light Source, and Richard Wolf 1.9mm/9.5 Fr 
Integrated Telescope (part number 8626.431). Four injections were performed per mouse. 
Mice then underwent colonoscopy eight weeks later to assess tumor formation. Colonoscopy 
videos and images were saved for offline analysis. Following sacrifice, the distal colons 
were excised and fixed in 10% formalin, then examined by hematoxylin and eosin section to 
identify adenomas. Histology images were reviewed by gastrointestinal pathologists who 
were blinded to the treatment groups (S.S., V.D., and O.H.Y.).
Statistics and animal models
All experiments reported in Figs 1, 2, 3, 4, and 5 were repeated at least three independent 
times except Figs 3a, 4c–d, which were repeated twice. All samples represent biological 
replicates. For murine organoid assays, 2–4 wells per group with at least 3 different mice 
were analyzed. For human organoid assays, 4 wells per group with 4 different patient 
samples were analyzed and experiments were repeated 4 times. All centre values shown in 
graphs refer to the mean. For statistical significance of the differences between the means of 
two groups, we used two-tailed Student’s t-tests. Statistical significance in Figure 3k was 
calculated by performing ANOVA multiple comparisons of the means for each group. No 
samples or animals were excluded from analysis, and sample size estimates were not used. 
Animals were randomly assigned to groups. Studies were not conducted blind with the 
exception of all histological analyses and Fig. 5c and 5h. All experiments involving mice 
were carried out with approval from the Committee for Animal Care at MIT and under 
supervision of the Department of Comparative Medicine at MIT.
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Extended Data
Extended Data Figure 1. HFD alters intestinal morphology and enhances intestinal progenitor 
proliferation
a–g, In comparison to mice fed a standard chow, mice on a HFD gained on average 50% 
mass (a, C: n=11, HFD: n=15), had reduced small intestinal mass and length (b,c, C: n=11, 
HFD: n=15), longer crypts and shorter villi (e,g, n=3 each), and fewer villus enterocytes (f, 
n=3). HFD did not change the density of crypts (d, n=3) in the proximal jejunum. The 
proximal jejunum was defined as the length between 6 and 9 cm as measured from the 
pylorus (the distal portion of the stomach).
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h–k, HFD enhanced BrdU incorporation in ISCs (or crypt base columnar cells) and 
progenitor cells (or transit-amplifying cells) in the proximal jejunum (h, n=6) and sorted cell 
populations (i, n=3) after a 4-hour pulse. HFD increased the total (j, control: n=4, HFD: 
n=5) and normalized numbers of BrdU-labeled enterocytes compared to controls after a 24-
hour pulse. Arrowhead (k) marks the leading edge of migrating BrdU-positive enterocyte.
l, m, Representative images of Olfm4 (l, n=3) and Crypt4 (m, n=6) in situ hybridizations 
from C and HFD mice.
n, No significant difference in the number of jejunal caspase3+ cells was detected by 
immunohistochemistry. Images are representative of three separate experiments (n=3); 
arrows indicate representative caspase3+ enterocytes.
o, The HFD chow (Research Diets D12492) provides a higher percentage of kilocalories 
from fat and conversely a lower percentage of kilocalories from protein and carbohydrates 
compared to standard chow diet (Labdiet RMH3000).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001, scale bars in g=100μm, h,i=50μm, k=100μm and 50μm 
(inset), l,m= 50μm and 20μm (inset), n=100μm; two separate fields of jejunum (d), and at 
least 15 crypts (e), 15 villi (f), 10 villi (g), 100 cells (i), 25 villi (j) and 25 crypt-villus units 
(n) were counted per sample in each independent experiment. ISCs= intestinal stem cells; 
Olfm4= Olfactomedin 4; Crypt4= Cryptdin 4; C= control; HFD= high fat diet)
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Extended Data Figure 2. HFD and PPAR-d signaling have minimal effects on enteroendocrine 
and goblet cell differentiation but promote intestinal regeneration after 15 Gy irradiation
a, b, Quantification (a, n=3) of immunostains (b, n=3) for chromogranin A revealed no 
difference in the numbers of jejunal enteroendocrine cells (arrowheads) per crypt-villus unit 
in HFD-fed mice and GW-treated mice compared to their respective controls.
c, d, Quantification (c, n=4) of Alcian blue/PAS staining (d, n=4) showed no difference in 
mucinous goblet cells (arrowhead) in HFD-fed mice and GW-treated mice compared to their 
respective controls.
e, f, HFD increased the number of regenerating crypts as measured by an increased number 
of crypts containing at least ten Ki67+ (a marker of proliferation) cells (e, n=3) or at least 
one Olfm4+ cell (f, n=3) per 5mm of jejunum by immunohistochemistry (IHC) or in situ 
hybridization (ISH). Arrows indicate Olfm4+ crypts.
g, Surviving crypt numbers after ionizing irradiation-induced (XRT) damage. Arrows: 
regenerating crypts. Asterisks: aborted crypts (n=3).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; scale 
bars in b, d=100μm, e, f=50μm and 20μm (inset), g=50μm; 50 crypt-villus units per sample 
were analyzed (a, c) and approximately 50 crypts (e, f, g) were counted per sample in each 
independent experiment. Olfm4= Olfactomedin 4; Crypt4= Cryptdin 4; C= control; HFD= 
high fat diet; V= vehicle; GW= PPAR-d agonist, GW501516)
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Extended Data Figure 3. A HFD and fatty acids do not activate inflammatory pathways in 
intestinal crypts and organoids, while HFD and enforced PPAR-d signaling enhance colonic 
stem-cell function
a, HFD did not alter the normalized expression levels of inflammatory genes from the gene 
set enrichment analysis (GSEA) MSigDB (signature M6557) data set in ISCs and 
progenitors.
b, HFD did not induce differential expression of Inflammatory Response genes from Gene 
Ontology (GO: 0006954) in ISCs (Lgr5-GFPhi) or progenitors (Lgr5-GFPlow) compared to 
C. Fold changes of GO Inflammatory Response genes are indicated in red, and fold changes 
for all other genes are indicated in blue.
c, HFD did not activate the NFκB or the STAT-3 pathways in the intestinal crypt. Total and 
phosphorylated protein levels in crypt lysates were assessed by immunoblots (n=3). For 
western blot source data, see Supplementary Figure 1.
d, HFD did not induce pro-inflammatory gene expression in ISCs (Lgr5-GFPhi) or 
progenitors (Lgr5-GFPlow). Relative expression levels compared to Actb were measured by 
qRT-PCR (n=5).
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e, Ex vivo PA, L or GW treatment did not induce inflammatory gene expression in crypt-
derived organoids compared to V. Relative expression levels compared to Actb were 
assessed by qRT-PCR (n=4, 12 wells per sample were analyzed).
f, HFD boosted the number of BrdU-labeled cells as measured in distal colonic crypts 
compared to C (C n=6, HFD n=5) after a 4-hour pulse.
g, HFD increased the frequency of colonic ISCs (Lgr5-GFPhi, dark green) and (Lgr5-
GFPlow, light green) cells (n=8).
h, i, HFD enhanced PPAR-d (h) and β-catenin (i) target gene expression in colonic ISCs and 
progenitors. Relative expression levels compared to Actb were determined by qRT-PCR 
(n=5, all fold changes are significant with P<0.05)
j–m, Colonic crypts derived from HFD-fed (j, n=4; k, n=4) and GW-treated (l, n=5; m, n=4) 
mice demonstrated greater primary and secondary organoid-forming capacity compared to 
their respective controls. Representative day 4 organoids are depicted.
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001, scale bars in f=50μm, j=100μm, l=200μm; 50 crypts per 
sample were analyzed (f) in each independent experiment. ISCs= intestinal stem cells; C= 
control; HFD= high fat diet; V= vehicle; GW= PPAR-d agonist, GW501516)
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Extended Data Figure 4. Characterization of HFD crypt and ISC-derived organoids
a, HFD organoids contained higher frequencies of ISCs (Lgr5-GFPhi) compared to C (n=3).
b, c, C and HFD organoids demonstrated no differences in morphologic ultrastructure as 
seen in (b) one micron sections of control (left) and HFD (right) organoids counterstained 
with Toluidine Blue and (c) electron microscopy images of representative C (left) and HFD 
(right) organoids (n=3). S=Stem-cell, P=Paneth cell.
d, e, Composition of organoids derived from C (d) and HFD (e) crypts as assessed by single-
cell gene expression analysis. Organoids on day 5 contained ISCs (Lgr5 and Olfm4, 
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Olfactomedin 4), Paneth cells (Lyz, Lysozyme), enteroendocrine cells (Chga, Chromogranin 
A), and goblet cells (Muc2, Mucin 2). 48 live cells per group were sorted and single-cell 
gene expression analysis was performed after pre-amplification using corresponding stem-
cell and lineage primers (See Materials and Methods).
f, Crypt-derived organoids from control or HFD mice included Chromogranin A-, Mucin 2-, 
and Lysozyme-positive cells as assessed by immunofluorescence (blue=DAPI, red=cell-
specific antibody). Images represent two experiments (n=2). blue: DAPI. red: cell-specific 
antibody.
g, Cultured villi from C and HFD mice lack the ability to form organoids. Images represent 
two experiments with 6 wells per sample (n=2).
h, ISCs from HFD-fed mice harbored greater organoid-forming potential compared to 
controls. Arrowheads indicate representative organoids at days 4, 7, 10 of culture (n=4).
i, Individually dissociated HFD primary organoids that were derived from single ISCs 
possessed more secondary organoid-forming ability than those from C. (n=4). 
Representative day 4 secondary organoids are illustrated.
j, k, Single-cell gene expression analysis revealed that ISCs from both control (j) and HFD 
(k) mice can beget Paneth cells (Lyz) within 24 hours in culture (48 cells per group, See 
Materials and Methods).
l, m, Composition of organoids derived from control (l) and HFD (m) ISCs (Lgr5-GFPhi) as 
assessed by single-cell gene expression analysis (48 cells per group, See Materials and 
Methods). Organoids on day 5 contained ISCs (Lgr5 and Olfm4), Paneth cells (Lyz), 
endocrine cells (Chga) and goblet cells (Muc2).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05; scale bars in b= 20μm, c=2μm, f=50μm, g,i=200μm, h=100μm. C= control; HFD= 
high fat diet)
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Extended Data Figure 5. Ex vivo exposure of mouse and human organoids to fatty acids 
recapitulates aspects of a HFD
a, b Individually dissociated primary organoids possessed more secondary organoid-forming 
activity (a, n=4, the mean number of secondary organoids subcloned from each of 5 primary 
organoids in 4 independent experiments.) and contained a higher frequency of Lgr5-GFPhi 
ISCs (b, n=3) after four weeks of treatment with 30μM PA compared to V.
c, Exposure of naïve crypts to 30μM OA had no effect on primary organoid formation 
measured at day 7 (n=6). Representative day 7 organoids depicted.
d, Individually dissociated primary organoids possessed more secondary organoid-forming 
capacity after four weeks of treatment with 30μM OA (n=4, the mean number of secondary 
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organoids subcloned from each of 5 primary organoids in 4 independent experiments.) 
compared to V (same vehicle cohort used in a and d).
e, Lipid mixture composition (Sigma L0288) as described by the manufacturer.
f, Ex vivo treatment of human-derived small intestinal crypts (H1–H4) passaged in the 
presence of L, PA, or GW augmented relative clonogenicity compared to V as shown in 
representative images from 4 independent experiments. H1: n= 10 (V, PA, GW) and n= 6 (L) 
wells were analyzed. H2: n= 16 (V), n= 6 (L), n= 12 (PA), and n= 14 (GW) wells were 
analyzed. H3: n= 10 (V), n= 12 (L, PA), and n= 8 (GW) wells were analyzed. H4: n= 7 (V, 
GW), n= 6 (L), and n= 9 (PA) wells were analyzed. Age, gender, and BMI are specified to 
the right of the bar graph panel.
g–j, Human crypt-derived organoids after ex vivo treatment with PA, L, or GW induced 
PPAR-d target gene expression as assessed in passaged cultures with qRT-PCR (n=4, 12 
wells per sample were analyzed, all fold changes are significant, P<0.05).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bar in c=100μm, f=500μm. ISCs= intestinal stem 
cells; V= vehicle; PA= palmitic acid; OA= oleic acid; L= lipid mixture; GW= PPAR-d 
agonist, GW501516)
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Extended Data Figure 6. PPAR-d is the predominant PPAR family member expressed in 
intestinal progenitors and mediates the effects of HFD
a, PPAR-d is the most abundant PPAR family member in ISCs (Lgr5-GFPhi) and progenitors 
(Lgr5-GFPlow) based on RNA-seq data.
b, Confirmation of PPAR family member mRNA expression levels in ISCs (Lgr5-GFPhi) 
and progenitors (Lgr5-GFPlow) by qRT-PCR (n=5).
c, Genes upregulated in HFD ISCs (Lgr5-GFPhi) versus control ISCs were enriched in PPAR 
and LXR/RXR motifs.
d, GSEA of RNA-seq data identified enrichment of PPAR-d targets in ISCs (Lgr5-GFPhi) 
and progenitors (Lgr5-GFPlow) with a HFD.
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e, Confirmation of induced PPAR-d target gene expression in flow sorted ISCs (Lgr5-GFPhi) 
and progenitors (Lgr5-GFPlow) by qRT-PCR (n=5). All fold changes were significant with 
P<0.05.
f, g, Representative images of Olfm4+ (ISCs, f) and Crypt4+ (Paneth cells, g) in situ 
hybridization (ISH) from V and GW-treated mice (f, n=3; g, n=4).
h, Ex vivo exposure of organoids to PA, L, or GW stimulated PPAR-d and β-catenin target 
gene expression (n=3, all fold changes were significant with P<0.05).
i, j, Injection with tamoxifen (4 injections on alternating days) in PpardL/L; Villin-CreERT2 
mice led to efficient intestinal deletion (IKO) of Ppard (7 days after the last tamoxifen dose) 
as assessed by allele-specific deletion PCR (i, n=3) and immunoblot analysis (j, n=3) of 
crypts. For western blot source data, see Supplementary Figure 1.
k, Acute disruption of Ppard (8 days after the last tamoxifen dose) did not perturb ISC and 
progenitor proliferation as determined 4-hours following BrdU administration (n=3).
l, m, Acute Ppard deletion (8 days after the last tamoxifen dose) did not significantly alter 
Olfm4+ ISCs numbers (L/L: n=5, IKO: n=4) (l) or Crypt4+ Paneth cell (n=5) (m) numbers 
as assessed by in situ hybridization.
n, Loss of Ppard transcripts in PPAR-d IKO organoids was confirmed by qRT-PCR using 
deletion-specific primers (n=3).
o, PPAR-d is required for the induction of PPAR-d and β-catenin target gene expression in 
secondary organoids after ex vivo PA, L, or GW treatment (n=5, all fold changes are 
significant with P<0.05)
p, Heat map of differentially expressed genes illustrated induction of a PPAR-d program in 
HFD-derived ISCs and progenitors relative to controls (C).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, scale bars in f, g, k–m=50μm and 20μm (inset); 50 crypts per sample were 
analyzed in each independent experiment (f, g, k–m). ISCs= intestinal stem cells; C= 
control; Olfm4= Olfactomedin 4; Crypt4= Cryptdin4; HFD= high fat diet; V= vehicle; PA= 
palmitic acid; L= lipid mixture; GW= PPAR-d agonist, GW501516)
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Extended Data Figure 7. HFD and PPAR-d signaling boost nuclear β-catenin localization and 
activity in intestinal progenitors
a, b, HFD-derived ISCs (a, Lgr5-GFPhi) and progenitors (b, Lgr5-GFPlow) required less 
Wnt3a and R-spondin to initiate organoids compared to C ISCs as measured by comparing 
organoid-formation in complete ENRW media, which includes EGF, Noggin, R-spondin, 
and Wnt3a, versus EN media, which includes EGF and Noggin but lacks Wnt3a and R-
spondin (n=3). C-derived progenitors, in contrast to HFD-derived progenitors, rarely formed 
organoids in either ENRW or EN media.
c–f, HFD increased nuclear β-catenin localization in flow sorted ISCs and progenitors from 
HFD (c, n=5) and GW-treated (d, n=4) mice as determined by immunofluorescence 
(red=DAPI, cyan=non-phosphorylated β-catenin, CST 8814S). At least 100 cells per sample 
were quantified. Representative images are shown in (e, f).
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g–i, HFD (g) and GW (h) treatment increased the numbers of ISCs and progenitors with β-
catenin+ nuclei as assessed by immunostains (n=4 each). Representative images are shown 
in (i); arrowheads indicate representative nuclear β-catenin in ISCs (red) and progenitors 
(black).
j–l, Association of PPAR-d and β-catenin in C and HFD derived intestinal crypts as shown 
by immunoprecipitation (IP) (n=3). For western blot source data, see Supplementary Figure 
1.
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in e,f=50μm i=20μm; organoid assays: 2–4 
wells per sample analyzed (a, b), 50 crypts per sample were analyzed in each independent 
experiment (g, h). ISCs= intestinal stem cells; C= control; HFD= high fat diet; V= vehicle; 
GW= PPAR-d agonist, GW501516)
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Extended Data Figure 8. HFD-mediated alterations in β-catenin target gene expression in single 
ISCs and progenitors
a, Heat map representation of β-catenin target gene expression in single ISCs (Lgr5-GFPhi, 
24 cells) and progenitors (Lgr5-GFPlow, 72 cells; See Materials and Methods).
b, Stem-cell signature genes were identified by comparing target gene expression in C ISCs 
(Lgr5-GFPhi) to C progenitors (Lgr5-GFPlow).
c, HFD signature genes were identified by comparing target gene expression in HFD to C 
ISCs (Lgr5-GFPhi).
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d, t-Distributed stochastic neighbor embedding (t-SNE) analysis of single cells using all β-
catenin target genes.
e, tSNE analysis of single cells using stem-cell signature genes.
f, tSNE analysis of single cells using HFD signature genes.
g, h, Lgr5 expression was similar in HFD ISCs (Lgr5-GFPhi) (g) and progenitors (Lgr5-
GFPlow) (h) as compared to their respective controls.
i, j, HFD increased the percentage of ISCs (Lgr5-GFPhi) (i) and progenitors (Lgr5-GFPlow) 
(j) with elevated Jag1 and Jag2 expression compared to their respective controls.
k, l, HFD (k, n=3) and GW treatment (l, n=4) augmented Jag1 expression compared to C 
and V treatments, respectively, as assayed by single-molecule in situ hybridization: Jag1 is 
broadly expressed throughout the crypt.
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05; scale bars in k, l=50μm and 20μm (inset); more than 50 crypts per sample were 
analyzed in each independent experiment (k, l). ISCs= intestinal stem cells; C= control; 
HFD= high fat diet; V= vehicle; GW= PPAR-d agonist, GW501516)
Extended Data Figure 9. Characterization of obese db/db mouse intestines
a–f, At 4–5 months of age, homozygous db/db gained on average 50% more mass (a, n=9), 
had increased small intestinal mass and length (b, c n=9), shallower crypts (d, n=4) and 
longer villi (e, f n=5) when compared to control db/+ mice.
g–h, Immunostains for Olfm4 (n=6) and lysozyme (n=6) revealed a slight reduction in the 
number of Olfm4+ ISCs and Paneth cells, respectively, in db/db mice compared to db/+ 
controls.
i, Organoid-forming capacity of db/db crypts trended higher (P=0.095) compared to db/+ 
controls (n=7).
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j, Single-cell gene expression analysis revealed no induction of PPAR-d or β-catenin target 
gene expression in live, enriched stem and progenitor cells that are depleted of secretory 
cells (7-AAD−Epcam+CD24−c−kit− cells, 48 cells per group; See Materials and Methods) 
from db/db intestines compared to control intestines.
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in f=100μm, g–h=50μm and 20μm (inset), 
i=200μm; and at least 30 crypts (d); 20 villi (e); 100 crypts (g, h) were assessed per sample 
in each independent experiment. All db/db and db/+ mice were fed a standard chow diet. 
ISCs= intestinal stem cells; OLFM4= Olfactomedin 4)
Extended Data Figure 10. PPAR-d activation bestows adenoma-initiating capacity to Apc-null 
progenitors
a, b, Representative optical endoscopy images (top) from Figure 5 with H&E (middle), and 
β-catenin (immunohistochemistry, bottom) sections of adenomas derived from orthotopic 
transplantation of Apc-null ISCs (a, Lgr5-GFPhi) and progenitors (b, Lgr5-GFPlow) from V 
and GW-treated mice 4 days post Apc deletion. Tumors exhibited hyperchromasia, lack of 
maturation, nuclear crowding, and nuclear β-catenin positivity. Two independent 
pathologists blinded to treatment groups interpreted the results.
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c, d. Apc deletion was confirmed in sorted small intestinal ISCs and progenitors from V and 
GW-treated ApcL/L; Lgr5-EGFP-IRES-CreERT2 mice 4 days after tamoxifen administration 
(c, n=3) and in isolated tumors (d, n=3) by PCR amplification using allele-specific deletion 
primers targeting exon14.
(Unless otherwise indicated, n represents independent experiments; scale bars in a 
(20X)=50μm and (60X)=20μm. ISCs= intestinal stem cells; V= vehicle; GW= PPAR-d 
agonist, GW501516)
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Figure 1. High Fat Diet augments ISC numbers and function
a, Quantification of Olfm4+ ISCs (n=3) and Crypt4+ Paneth cells (n=6) in the proximal 
jejunum of C and HFD mice by in situ hybridization.
b, BrdU incorporation in ISCs (crypt base columnar cells) and progenitors (transit-
amplifying cells) after a 4-hour pulse (n=6).
c, d, e, Organoid per crypt (c, n=4) and crypt domain (d, n=7) quantification from C and 
HFD mice (d, n=4). Representative images: Day 7 organoids (e). Arrows: organoids. 
Asterisks: aborted crypts.
f, Number of secondary organoids per dissociated crypt-derived primary organoid (n=9 
primary organoids, 3 primary organoids per sample were individually subcloned in 3 
independent experiments).
g, h Frequencies of ISCs (Lgr5-GFPhi, dark green) and progenitors (Lgr5-GFPlow, light 
green) in the entire small intestine (g, n=10) and colon (h, n=8) as measured by flow 
cytometry.
i, j, Organoid-initiating capacity of C and HFD ISCs cultured +/− Paneth cells (i, n=4). 
Representative images: Day 5 primary organoids (arrows, j).
k, Number of secondary organoids per dissociated ISC-derived primary organoid (n=4).
l, m, Crypts (l) and ISCs (m) isolated from HFD mice that were reverted to a standard chow 
diet (HFNC) retained augmented organoid-forming capacity for one week (red; n=4) but not 
for one month (blue; n=4) when compared to their HFD counterparts (n=6 crypts, n=4 
ISCs).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in a,b=20μm, e,j=100μm; histological analysis: 
a, Olfm4: 10 crypts/group, Crypt4: 50 crypts/group; b, 50 crypts/group in each experiment. 
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ISCs= intestinal stem cells; Olfm4= Olfactomedin 4; Crypt4= Cryptdin 4; C= control; HFD= 
high fat diet)
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Figure 2. Ex vivo exposure of intestinal organoids to palmitic acid recapitulates aspects of a HFD
a, Clonogenicity of naïve crypts cultured with 30μM PA in primary organoid cultures (n=5). 
Representative images: Day 4 organoids.
b, c, Secondary organoid formation of one thousand sorted live primary organoid cells after 
four weeks of 30μM PA treatment (b, n=3). Representative images: Day 4 secondary 
organoids (arrows, c).
d, e, Frequency (d) and organoid initiation (e) of ISCs (Lgr5-GFPhi) after four weeks of 
30μM PA exposure (d, n=3; e, n=4).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01; scale bars in a=100μm, c=100μm, 50μm (inset). ISCs= intestinal stem 
cells; V= vehicle; PA= palmitic acid)
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Figure 3. Activated PPAR-d in ISCs mediates the effects of a HFD
a, Immunoblots of PPAR-d target proteins in flow sorted ISCs (Lgr5-GFPhi) and progenitors 
(Lgr5-GFPlow) from C, HFD, V, and GW mice(n=2).
b, Quantification of Olfm4+ ISCs (n=4) and Crypt4+ Paneth cells (n=3) by in situ 
hybridization in proximal jejunal crypts.
c, BrdU incorporation in ISCs (crypt base columnar cells adjacent to Paneth cells) and 
progenitors (transit-amplifying cells not adjacent to Paneth cells) after a 4-hour pulse (n=4).
d, Organoid per crypt from V and GW-treated mice (n=3).
e, Frequencies of flow sorted ISCs (Lgr5-GFPhi) and progenitors (Lgr5-GFPlow) (n=5) from 
the entire small intestine of V and GW-treated mice.
f, Organoid-initiating capacity of ISCs derived from V and GW-treated mice. Representative 
images: Day 12 organoids (n=5).
g, Frequency of ISCs (Lgr5-GFPhi) in organoids after 14 days of ex vivo GW exposure 
(n=3).
h, i, j, Primary (h, n=5) and secondary (i, j, n=5; normalized to V) organoid-forming 
capacity of control and PPAR-d intestinal knockout (IKO) mice upon ex vivo treatment with 
V, PA, L, and GW. Representative images: Day 4 secondary organoids (j).
k, Normalized clonogenicity of human-derived intestinal organoids after ex vivo treatment 
with PA, L, and GW in secondary culture (n=4, See Materials and Methods).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in b,d=20μm, f=200μm, j=100μm; histological 
analysis: b, Olfm4: 15 crypts/group, Crypt4: 50 crypts/group; c, 50 crypts/group in each 
experiment. For western blot source data, see Supplementary Figure 1. ISCs= intestinal stem 
cells; Olfm4= Olfactomedin 4; Crypt4= Cryptdin 4; C= control; HFD= high fat diet; V= 
vehicle; GW= PPAR-d agonist, GW501516; PA= palmitic acid; L= lipid mixture)
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Figure 4. HFD-induced PPAR-d signaling induces expression of a subset of β-catenin target genes
a, b, Organoid per crypt quantification from HFD-fed (a) and GW-treated (b) mice with 
indicated concentrations of Wnt3a. Representative images: Day 4 organoids (n=5).
c, d, e, f, Violin plots for most induced β-catenin target genes in ISCs (Lgr5-GFPhi) from 
HFD-fed (c) and GW-treated mice (d) (24 single cells/group), and in progenitors (Lgr5-
GFPlow) from HFD-fed (e) and GW-treated mice (f) (72 single cells/group; See Materials 
and Methods).
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in a,b=100μm. ISCs= intestinal stem cells; C= 
control; HFD= high fat diet; V= vehicle; GW= PPAR-d agonist, GW501516)
Beyaz et al. Page 38
Nature. Author manuscript; available in PMC 2016 September 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. PPAR-d activation confers organoid and tumor-initiating capacity to non-stem-cells
a, b, Representative spontaneous intestinal tumor from a HFD mouse: gross image (a) and 
microscopic H&E image (b).
c, Incidence of spontaneous intestinal low-grade dysplastic lesions (adenoma) and 
carcinomas in C (n=19) and HFD (n=25) mice.
d, e, Organoid-initiating capacity of progenitors (Lgr5-GFPlow) from HFD (n=7) and GW-
treated (n=5) mice. Representative images: Day 7 organoids (e).
f, Schematic assessing in vitro and in vivo adenoma-initiating capacity of Apc-null ISCs 
(Lgr5-GFPhi) and progenitors (Lgr5-GFPlow) from V and GW-treated mice 
(Tam=tamoxifen).
g, Numbers and representative day 5 images of adenomatous organoids from Apc-null ISCs 
(Lgr5-GFPhi) and progenitors (Lgr5-GFPlow) treated +/− GW in EN media (EGF and 
Noggin only) (n=6).
h, Optical colonoscopy of tumors formed after orthotopic transplantation of Apc-null ISCs 
(Lgr5-GFPhi) and Apc-null progenitors (Lgr5-GFPlow) from V and GW-treated mice (n=5).
i, A model of intestinal adaptation to HFD: mechanistically, HFD activates a PPAR-d-
mediated program that augments the organoid and tumor-initiating capacity of intestinal 
progenitors. A feature of the PPAR-d program includes induction of a subset of β-catenin 
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target genes. S= stem-cell, P= Paneth cell, Pr= progenitor cell, T= tumor cell, red dotted 
line= Apc-null cells with tumor-forming capability.
(Unless otherwise indicated, data reflect mean ± s.d. from n independent experiments; 
*P<0.05, **P<0.01, ***P<0.001; scale bars in b=50μm, e=200μm, g=200μm (upper) and 
50μm (lower). ISCs= intestinal stem cells; C= control; HFD= high fat diet; V=vehicle; GW= 
PPAR-d agonist, GW501516)
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